PLX PHARMA INC. XXXBANKRUPTCY EFF: 10/02/23
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PLX PHARMA INC. XXXBANKRUPTCY EFF: 10/02/23 COMMON STOCK, CUSIP 72942A107.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PLX PHARMA INC. XXXBANKRUPTCY EFF: 10/02/23 COMMON STOCK, CUSIP 72942A107.